US HB148 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 3 2019 - 25% progression, died in committee
Action: 2019-01-25 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 3 2019 - 25% progression, died in committee
Action: 2019-01-25 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Title
Byron Nash Renal Medullary Carcinoma Awareness Act of 2019
Sponsors
Rep. Al Green [D-TX] | Rep. Sheila Jackson-Lee [D-TX] | Rep. Marc Veasey [D-TX] |
History
Date | Chamber | Action |
---|---|---|
2019-01-25 | House | Referred to the Subcommittee on Health. |
2019-01-03 | House | Referred to the House Committee on Energy and Commerce. |
2019-01-03 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/148/all-info |
Text | https://www.congress.gov/116/bills/hr148/BILLS-116hr148ih.pdf |